circ-0007707/miR-429/PDGFD Pathway Regulates the Progression of Gastric Cancer by Modulating the Immune-Gene Signature

Table 1

Patients’ characteristic.

Clinical features	Number
Survival status
Alive	235 (61.20%)
Dead	149 (38.80%)
Age
≥67	199 (51.82%)
<67	185 (48.18%)
Sex
Female	142 (36.98%)
Male	242 (63.02%)
Grade
G1	8 (2.08%)
G2	133 (34.64%)
G3	243 (63.28%)
Stage
Stage I	51 (13.28%)
Stage II	121 (31.51%)
Stage III	170 (44.27%)
Stage IV	42 (10.94%)
T
T1	19 (4.95%)
T2	79(20.57%)
T3	181 (47.14%)
T4	105 (27.34%)
M
M0	357 (92.97%)
M1	27 (7.03%)
N
N0	123 (32.03%)
N1	102 (26.56%)
N2	79 (20.57%)
N3	80 (20.83%)